Home › Encyclopedia › Alexamorelin: Research Status and Available Data
Research / Unapproved

Alexamorelin: Research Status and Available Data

Molecular formulaC50H63N13O7
Molecular weight958.1 g/mol
Registered trials0
PubChem CID10011122

Regulatory Status

Alexamorelin is an unapproved research compound. It has no FDA-approved label, no approved brand name, and no approved indication. There is currently no clinical trial record for this compound in the registry checked for this profile.

What Alexamorelin Is

Alexamorelin is a synthetic peptide with the molecular formula C50H63N13O7 and a molecular weight of approximately 958.1 g/mol. Its structure includes amino acid-like building blocks linked into a single chain, a pattern typical of research peptides. The compound is catalogued under PubChem CID 10011122, which provides a unique chemical reference but no information about safety or effect in humans.

Trial Footprint

No clinical trials for alexamorelin are currently registered. Because no trials have been identified, there is no phase, enrollment, or outcome information to report at this time.

FAQ

Is alexamorelin FDA approved?
No. Alexamorelin has no FDA-approved label, no approved brand name, and no approved medical use. It is classified as an unapproved research compound.
What is alexamorelin used for?
There is no approved use for alexamorelin. Without an FDA label or clinical trial data, no therapeutic use can be stated.
Are there clinical trials studying alexamorelin?
No clinical trials for alexamorelin are currently registered. This means there is no available data on dosing outcomes, safety signals, or efficacy in humans.
What is known about the chemical structure of alexamorelin?
Alexamorelin has the molecular formula C50H63N13O7 and a molecular weight of about 958.1 g/mol. It is listed in PubChem under CID 10011122, which serves as a chemical identifier rather than a safety indicator.
Is there safety data available for alexamorelin?
No adverse event reports or safety data are currently available for alexamorelin. The absence of label and trial information means no safety profile can be described.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem

Updated 2026-11-07